By continuing on our website, you agree to our use of the cookie for statistical and personalization purpose. Learn More Explore our newly updated, enhanced, and expanded International Health Care System Profiles to learn how 31 countries across six continents approach…
Massive companies that oversee prescriptions for tens of millions of Americans will soon be required to provide detailed information on how much money they make from drugmakers, under a new regulation released Thursday by the Trump administration. Under the Labor…
The impact on newer immunotherapy drugs is likely to be limited, as several remain single-source medicines with no competing generic versions The NPPA has capped trade margins at 30 per cent for 137 non-scheduled anti-cancer medicines, with price reductions of up to…
We're there for consumers when it counts — with the right information, right on time. 70,000+ consumer news stories published ConsumerAffairs is a for-profit company. Your contribution is not tax deductible. Missouri Attorney General Catherine Hanaway has ordered Eli Lilly to stop…
How medical freedom was eroded, and what it will take to restore it. If you raise cows and a feed mill sells you a contaminated batch, you can take the mill to court. The same holds for the dealer who…
Experts at AMCP Nexus say biosimilar launches should prompt payers to revisit step therapy and measure value beyond market share. About 90% of dispensed biologics in British Columbia, the first Canadian province to adopt mandatory switching, are biosimilars, O’Rourke said.2 Manitoba…
WASHINGTON (October 27, 2026) — The Council for Innovation Promotion (C4IP) today raised concerns about potential unintended consequences for American biotechnology innovation under the U.S. Treasury Department’s proposed efforts to protect national security through restrictions on certain outbound investments. C4IP is concerned that the proposal’s…
AMCP leaders say PBM reform, new drug pricing models and AI will shape this week’s Nexus meeting in San Diego. Leaders from the Academy of Managed Care Pharmacy (AMCP) spoke with Managed Healthcare Executive about what attendees can expect and…
New Delhi: Agra-based paediatric surgeon Sanjay Kulshrestha has urged the Supreme Court to constitute an expert committee to examine gaps in the existing drug-pricing framework, arguing that the...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for more than three decades. His stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is…
Drug-price policy: most-favoured-nation pricing, TrumpRx, pharmaceutical tariffs and price deals with drug makers.
An article joins this feed when it matches these terms. Each one is also a search of its own.